After reviewing new data that proves hormone replacement therapy does not increase a woman’s risk of receiving a breast cancer diagnosis, the FDA has removed the black box label.

AI transforms healthcare by enhancing disease detection, patient care and hospital efficiency but requires careful implementation to ensure equity and effectiveness. Managed Healthcare Executive sought for common themes in where AI currently stands in healthcare by analyzing our past coverage in the past.

Here’s what you missed this week on Managed Healthcare Executive.

An off-target interaction with nuclear receptor PPARγ may trigger a sequence of events that results in lung injury.

Milliman’s Jennifer Cruz says plans are losing rebates because of steep price discounts negotiated under the Inflation Reduction Act. but that they need to be sure that renegotiation of rebate guarantees doesn’t get too broad.

Pharmacy benefit managers are approaching health plans with value-based contracts that consider lower costs on the medical benefit of the insurance, says Jennifer Cruz of Milliman.

AI and virtual care revolutionize dermatology, enhancing melanoma detection, expanding patient access and improving efficiency in clinical practices.

New interim safety and efficacy data for primary biliary cholangitis (PBC) treatment Livdelzi (seladelpar) demonstrates sustained itch relief and the potential to slow disease progression.